Surgery Partners Inc (NASDAQ:SGRY) has been assigned an average rating of “Hold” from the seven brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $15.50.
A number of brokerages have recently issued reports on SGRY. Citigroup raised their price objective on Surgery Partners from $10.00 to $15.00 and gave the stock a “buy” rating in a research report on Wednesday, May 13th. Royal Bank of Canada restated a “buy” rating and set a $14.00 price objective on shares of Surgery Partners in a research report on Wednesday, May 13th. ValuEngine downgraded Surgery Partners from a “strong-buy” rating to a “buy” rating in a research report on Thursday, April 2nd. Benchmark upgraded Surgery Partners from a “hold” rating to a “buy” rating and set a $14.00 price objective for the company in a research report on Monday, April 27th. Finally, BidaskClub downgraded Surgery Partners from a “hold” rating to a “sell” rating in a research report on Saturday, June 27th.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Bank of Montreal Can grew its stake in Surgery Partners by 32.4% during the fourth quarter. Bank of Montreal Can now owns 3,865 shares of the company’s stock worth $61,000 after purchasing an additional 946 shares during the period. Two Sigma Advisers LP acquired a new stake in Surgery Partners during the first quarter worth approximately $76,000. Royal Bank of Canada grew its stake in Surgery Partners by 199.9% during the first quarter. Royal Bank of Canada now owns 16,156 shares of the company’s stock worth $106,000 after purchasing an additional 10,769 shares during the period. Jefferies Group LLC grew its stake in Surgery Partners by 22.7% in the fourth quarter. Jefferies Group LLC now owns 18,586 shares of the company’s stock valued at $291,000 after acquiring an additional 3,433 shares during the period. Finally, Citigroup Inc. grew its stake in Surgery Partners by 247.4% in the first quarter. Citigroup Inc. now owns 18,713 shares of the company’s stock valued at $122,000 after acquiring an additional 13,327 shares during the period. 93.05% of the stock is owned by institutional investors and hedge funds.
Surgery Partners stock traded down $0.40 during trading hours on Friday, hitting $11.18. The stock had a trading volume of 553,295 shares, compared to its average volume of 707,907. The company has a quick ratio of 1.37, a current ratio of 1.49 and a debt-to-equity ratio of 2.84. The stock has a market cap of $585.00 million, a price-to-earnings ratio of -4.60 and a beta of 3.43. Surgery Partners has a one year low of $4.00 and a one year high of $19.74. The business’s 50 day simple moving average is $12.53 and its 200-day simple moving average is $12.91.
Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Monday, May 11th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.62) by $0.28. Surgery Partners had a negative return on equity of 2.21% and a negative net margin of 4.38%. The company had revenue of $441.00 million during the quarter, compared to the consensus estimate of $377.50 million. Research analysts anticipate that Surgery Partners will post -1.34 EPS for the current fiscal year.
Surgery Partners Company Profile
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.